Shanghai RAAS Blood Products Co Ltd (002252):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai RAAS Blood Products Co Ltd (002252) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12935
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Shanghai RAAS Blood Products Co Ltd (002252) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shanghai RAAS Blood Products Co Ltd (Shanghai RAAS) is a biotechnology company that researches, develops, manufactures and distributes blood products (plasma derived medicinal products). The company’s products include human serum albumin, intravenous human immunoglobulin, other blood products, Chinese medicine products and other products. Its products focus on hematology, immunology and intensive care medicine areas. Shanghai RAAS also exports blood products to foreign countries. The company has plasma collection stations across China. Its subsidiaries include Tonrol Bio-Pharmaceutical Co., Ltd., that is involved in product development, production and marketing; and Zhengzhou RAAS Blood Products Company. Shanghai RAAS is headquartered in Fengxian District, Shanghai, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Shanghai RAAS Blood Products Co Ltd – Key Facts 5
Shanghai RAAS Blood Products Co Ltd – Key Employees 6
Shanghai RAAS Blood Products Co Ltd – Major Products and Services 7
Shanghai RAAS Blood Products Co Ltd – History 8
Shanghai RAAS Blood Products Co Ltd – Company Statement 9
Shanghai RAAS Blood Products Co Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Shanghai RAAS Blood Products Co Ltd – Business Description 12
R&D Overview 12
Shanghai RAAS Blood Products Co Ltd – SWOT Analysis 13
SWOT Analysis – Overview 13
Shanghai RAAS Blood Products Co Ltd – Strengths 13
Shanghai RAAS Blood Products Co Ltd – Weaknesses 14
Shanghai RAAS Blood Products Co Ltd – Opportunities 15
Shanghai RAAS Blood Products Co Ltd – Threats 16
Shanghai RAAS Blood Products Co Ltd – Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios – Capital Market Ratios 18
Financial Ratios – Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios – Interim Ratios 23
Financial Ratios – Ratio Charts 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 26
Shanghai RAAS Blood Products Co Ltd, Recent Deals Summary 27
Section 5 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Shanghai RAAS Blood Products Co Ltd, Key Facts 5
Shanghai RAAS Blood Products Co Ltd, Key Employees 6
Shanghai RAAS Blood Products Co Ltd, Major Products and Services 7
Shanghai RAAS Blood Products Co Ltd, History 8
Shanghai RAAS Blood Products Co Ltd, Subsidiaries 10
Shanghai RAAS Blood Products Co Ltd, Key Competitors 17
Shanghai RAAS Blood Products Co Ltd, Ratios based on current share price 18
Shanghai RAAS Blood Products Co Ltd, Annual Ratios 19
Shanghai RAAS Blood Products Co Ltd, Annual Ratios (Cont...1) 20
Shanghai RAAS Blood Products Co Ltd, Annual Ratios (Cont...2) 21
Shanghai RAAS Blood Products Co Ltd, Interim Ratios 23
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 26
Shanghai RAAS Blood Products Co Ltd, Recent Deals Summary 27
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
Shanghai RAAS Blood Products Co Ltd, Performance Chart (2013 - 2017) 22
Shanghai RAAS Blood Products Co Ltd, Ratio Charts 24
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 26

★海外企業調査レポート[Shanghai RAAS Blood Products Co Ltd (002252):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transpacific Industries Group Ltd. (TPI):企業の財務及び戦略的SWOT分析
    Summary Transpacific Industries Group Ltd. (Transpacific) is a waste management company that offers service in management of waste, recycling, regulatory compliance, protection and enhancement of the environment and industrial services. The company’s products include parts washing equipment and asso …
  • Richardson Electronics, Ltd. (RELL):企業財務及び戦略的SWOT分析
    Summary Richardson Electronics, Ltd. (Richardson Electronics) is a provider of engineered solutions, power grid and microwave tubes and consumables; displays, flat panel detector solutions and parts for diagnostic imaging equipment; power conversion and RF and microwave components; and customized di …
  • Veresen, Inc. (formerly Fort Chicago Energy Partners L.P.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Veresen, Inc. (formerly Fort Ch …
  • Zebra Technologies Corp.の企業概要及び財務/SWOT分析
    Zebra Technologies Corp. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Zebra Technologies Corp. annual and quarterly forecasts made by stock market experts. The report also …
  • Powerco Ltd:発電所・企業SWOT分析
    Powerco Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • MindTree Ltd.:企業の戦略・SWOT・財務分析
    SummaryMindTree Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Meridian Energy Ltd (MEL)-エネルギー分野:企業M&A・提携分析
    Summary Meridian Energy Ltd (Meridian Energy) is a state-owned energy utility that generates, trades and retails electricity. It utilizes renewable energy sources such as wind and water for generation of electricity. It also procures electricity from the wholesale electricity market. The company sup …
  • Huadian Power International Corporation Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Huadian Power International Cor …
  • Cochin Shipyard Ltd (COCHINSHIP):企業の財務・戦略的SWOT分析
    Cochin Shipyard Ltd (COCHINSHIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • NextEra Energy Inc (NEE):電力:M&Aディール及び事業提携情報
    Summary NextEra Energy, Inc. (NEE), formerly FPL Group, Inc., is an electric power and energy infrastructure company that generates, transmits and distributes electricity together with its subsidiaries. The company generates power through various sources such as nuclear, coal, oil and natural gas-fi …
  • Distilleries Company of Sri Lanka PLC:企業の戦略・SWOT・財務情報
    Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report Summary Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • WestSide Corporation Limited (WCL):企業の戦略的SWOT分析
    Summary Westside Corporation Limited (Westside) is an oil and gas company that explores and produces coal seam gas. The company’s gas seam projects include Meridian SeamGas CSG fields, Paranui ATP 769P, Tilbrook ATP 688P and Mount Saint Martin ATP 688P. Its Paranui ATP 769P is located in the south o …
  • Interferie S.A.:企業の戦略・SWOT・財務分析
    Interferie S.A. - Strategy, SWOT and Corporate Finance Report Summary Interferie S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Odisha Hydro Power Corporation Ltd.:企業のM&A・提携動向(発電分野)
    Summary Odisha Hydro Power Corporation Ltd. (OHPC) is an alternative energy company that acquires, develops and operates hydro, thermal and nuclear electric generating stations. The company offers hydro electric, thermal and nuclear electric power. It studies, investigates, collects information and …
  • The Wharf (Holdings) Limited:企業の戦略・SWOT・財務分析
    SummaryThe Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • Equity Assurance plc:企業の戦略・SWOT・財務情報
    Equity Assurance plc - Strategy, SWOT and Corporate Finance Report Summary Equity Assurance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Eldorado Gold Corporation:企業のM&A・事業提携・投資動向
    Eldorado Gold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eldorado Gold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Television Francaise 1 SA:企業の戦略・SWOT・財務情報
    Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report Summary Television Francaise 1 SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Genomma Lab Internacional S.A.B. de C.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Genomma Lab Internacional S.A.B …
  • Auris Medical Holding AG (EARS):製薬・医療:M&Aディール及び事業提携情報
    Summary Auris Medical Holding AG (Auris Medical) is a clinical-stage biopharmaceutical company with focus on neurotology and mental health supportive care. The company’s pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, post-acute inne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆